Navigation Links
Drug compound leads to death of ovarian cancer cells resistant to chemotherapy
Date:4/17/2008

In a discovery that may be useful for maintaining remission in chemo-resistant ovarian cancer, Yale scientists report that pre-clinical studies have shown the drug compound NV-128 can induce the death of ovarian cancer cells by halting the activation of a protein pathway called mTOR.

Gil Mor, M.D., associate professor in the Department of Obstetrics, Gynecology & Reproductive Sciences at Yale School of Medicine, and associate research scientist Ayesha Alvero, M.D. presented the data April 15 during an oral presentation at the annual meeting of the American Association for Cancer Research.

In cancer cells, mTOR signals enhance tumor growth and may be associated with resistance to conventional therapies. Inhibition of mTOR could shut down many of these survival pathways, including proteins that protect the mitochondria of cancer cells.

NV-128, developed by Novogen Limited, holds promise as a more targeted therapy for ovarian cancer because it works differently from traditional therapies that are dependent on enzymes known as caspases to trigger cell death. Therapies using caspases to kill cancer cells can be ineffective in chemo-resistant cancer cells due to mutations that short-circuit signals that trigger cancer cell death.

We consider that the capacity of NV-128 to trigger caspase-independent cell death, in otherwise chemoresistant ovarian cancer cells, opens new possibilities for the use of NV-128 as a potential addition to conventional chemotherapy targeting ovarian cancer cells, said Mor.

In the context of developing therapies for late stage ovarian cancer, Mor said, the finding may be a key step to the development of alternative targeted therapy for patients with cancer recurrence.


'/>"/>

Contact: Karen N. Peart
karen.peart@yale.edu
203-432-1326
Yale University
Source:Eurekalert  

Page: 1

Related medicine news :

1. AWWA Urges Science-Based Approach in Addressing Pharmaceutical Compounds in Water
2. The good and bad side of anti-cancer compounds
3. Study validates Pittsburgh Compound-B in identifying Alzheimers disease brain toxins
4. WRAIR investigators pioneering work on an exciting new class of antimalarial compounds
5. Soy compound may halt spread of prostate cancer
6. Drosophila drug screen for fragile X syndrome finds promising compounds and potential drug targets
7. Stevens chemists identify compounds to lure nutria, a rat-like pest ravaging Gulf Coast wetlands
8. Lixte Biotechnology Holdings, Inc. Announces Further Developments Regarding the Anti-Cancer Activity of Its Patent-Pending Proprietary Compounds
9. Researcher of the University of Navarra discovered potential antidepressant compounds
10. DDT Compound Speeds Breast Cancer Growth
11. Novel compound may lessen heart attack damage
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drug compound leads to death of ovarian cancer cells resistant to chemotherapy
(Date:7/11/2014)... July 11, 2014 Utilizing the Keller ... Dr. William Koenig, has topped a record number of ... has performed over 400 successful procedures without the occurrence ... is well known across the country for his expertise ... record has long been the foundation for numerous studies ...
(Date:7/11/2014)... 2014 (HealthDay News) -- In people with sex addiction, ... to that seen in drug addicts as they consume ... differences in brain activity between patients who have compulsive ... of drug addicts," study author Dr. Valerie Voon, of ... university news release. Voon,s research involved 19 men ...
(Date:7/11/2014)... 11, 2014 (HealthDay News) -- U.S. health officials have ... exposed to live anthrax during a safety mishap last ... and Prevention officials have announced a moratorium on the ... government labs. In a report issued Friday, the ... make sure a similar incident doesn,t occur again. Last ...
(Date:7/11/2014)... The report “Probiotics Market by Products (Functional ... (Regular, Therapeutic, Preventive Health Care) & Ingredients (Lactobacilli, ... 2019 ” defines and segments the global probiotics ... market value of probiotic products and ingredients. The ... for the global market with an analysis of ...
(Date:7/11/2014)... 11, 2014 According to a new ... Market by Communication Technology (ZigBee, Z-Wave, Bluetooth, Wi-Fi, NFC, ... Automotive & Transportation, Agriculture) & Geography - Global Trends ... Internet of Things market was worth $1029.5 Billion in ... 2020, at an estimated CAGR of 4.08% from 2014 ...
Breaking Medicine News(10 mins):Health News:Rochester Surgeon Hits Milestone with Keller Funnel 2Health News:Brains of Sex Addicts May Be Wired Like Those of Drug Addicts, Study Finds 2Health News:CDC Issues Tough Report on Anthrax Scare 2Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 2Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 3Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 4Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 5Health News:Internet of Things Technology & Application Market Worth $1423.09 Billion by 2020 – New Report by MarketsandMarkets 2Health News:Internet of Things Technology & Application Market Worth $1423.09 Billion by 2020 – New Report by MarketsandMarkets 3Health News:Internet of Things Technology & Application Market Worth $1423.09 Billion by 2020 – New Report by MarketsandMarkets 4
... Israel, April 29 Elbit Imaging Ltd.,(the "Company") (Nasdaq: ... by,Aurora Fidelity Trust Company Ltd., the trustee for the ... the Company (the "Trustee" and the "Notes",respectively), that due ... accounting firms, Zohar, Zohar & Co., the controlling shareholder ...
... levels increasing even within normal range associated with dangers ... of thyrotropin within the normal range may increase the ... Norwegian study finds. , Thyrotropin, a hormone produced by ... acts on the thyroid gland to stimulate its growth ...
... and sanitation, a new report co-authored by an expert at ... be done. , A major survey in Kazakhstan found that, ... a large number of people reported suffering from illnesses like ... Development Goal is to halve the number of people without ...
... in German . , Leipzig. Unlike in ... Republic and Poland did not so far lead to massive ... there are other reasons for the presence of empty apartments, ... findings of a research project conducted by the Helmholtz Centre ...
... -- More than 6,000 internists (doctors of internal ... will meet in Washington, D.C., for Internal Medicine ... College of Physicians (ACP), from May 15 - ... , Internal Medicine 2008 is the largest continuing ...
... 5-Star overall winner to launch Partner Enablement ... Program; prepares for significant partner growth, ENGLEWOOD CLIFFS, ... and recovery service provider and recent Gold,5-Star overall winner ... Partner Enablement Program at Interop 2008 in Las Vegas, ...
Cached Medicine News:Health News:Elbit Imaging Ltd. Announces Termination of Service of Trustee for Holders of Series A, B and C Notes 2Health News:Elbit Imaging Ltd. Announces Termination of Service of Trustee for Holders of Series A, B and C Notes 3Health News:Pituitary Hormone May Boost Women's Heart Risk 2Health News:Safe water? Lessons from Kazakhstan 2Health News:Shrinkage and aging are Europe-wide challenges 2Health News:Shrinkage and aging are Europe-wide challenges 3Health News:Shrinkage and aging are Europe-wide challenges 4Health News:ACP hosts largest medical education meeting for general and subspecialty internists 2Health News:Intronis Technologies to Launch Partner Enablement Program at INTEROP 2008 2
(Date:7/11/2014)... -- Australian drug delivery company, Phosphagenics Limited (ASX: POH; OTCQX: ... via a placement of A$16.3 million to institutional investors ... Asia and Australia ... (SPP) to be offered to existing shareholders.  The placement ... "This capital raising positions us strongly to ...
(Date:7/11/2014)... LONDON , July 11, 2014 /PRNewswire/ ... of visitors to Safety & Health Expo ... by the move to London ... senior management attending exhibition.     ... (Photo: http://photos.prnewswire.com/prnh/20140711/696892-a ) ...
(Date:7/10/2014)... 2014  Breg, Inc., a premier provider of ... FreeRunner™ knee brace with new innovations to help ... return to active lifestyles.  FreeRunner,s patent-pending design acts ... support when patients need it most, and the ... Patellofemoral issues are the most common cause ...
Breaking Medicine Technology:Phosphagenics' A$19.3 million Capital Raising 2Phosphagenics' A$19.3 million Capital Raising 3UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 2UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 3UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 4Breg Introduces Knee Brace to Help Runners with Patellofemoral Pain Syndrome 2
... WASHINGTON, Oct. 8 As Congress wraps up work ... of Transplantation,s (AST) Public Policy Committee arrived on Capitol ... health care provision that would ensure kidney transplant recipients ... The Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients ...
... Adnavance Technologies Inc., a developer of direct detection ... Randy White, Ph.D. chief executive officer, will present initial ... clinical samples during company presentations at the following conferences: ... at 10:00 a.m. Eastern Time at the Walter E. ...
Cached Medicine Technology:AST on Capitol Hill to Promote Transplant Drug Extension Provision With Senate as Part of Health Care Reform 2Adnavance Technologies to Present Initial Data Supporting Direct Detection Molecular Diagnostic Tests at AdvaMed 2009 and BIOCOM Investor Conference 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: